BrightmindAI develops personalized, AI-powered neurotechnology solutions for at-home brain health management. The company utilizes closed-loop, non-invasive brain stimulation, such as transcranial magnetic stimulation, to optimize neural activity. Its initial application focuses on providing migraine prevention with a user-validated stimulation headset.
Funding
$6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Migraine sufferers often experience dissatisfaction with existing treatment options, with a significant percentage finding current solutions ineffective in preventing or reducing migraine attacks. Traditional methods may not provide adequate relief or may come with undesirable side effects, leaving a large population seeking alternative solutions.
Solution
Brightmind.AI offers a personalized brain stimulation headset designed for at-home use to prevent migraines. The device utilizes transcranial magnetic stimulation (TMS) and advanced brain monitoring to optimize neural activity. The closed-loop, non-invasive approach aims to reduce the frequency and intensity of migraine attacks. By leveraging AI-powered personalization, the headset tailors stimulation protocols to individual user needs, potentially offering a more effective and convenient solution compared to traditional treatments.
Target Audience
The primary target audience includes individuals who experience migraines and are seeking alternative or more effective at-home treatment options, as well as neurologists and headache specialists looking for innovative solutions for their patients.
Features
- Personalized transcranial magnetic stimulation (TMS) protocols
- Advanced brain monitoring for real-time neural activity optimization
- Closed-loop system adapting to individual user responses
- User-validated form factor for comfortable at-home use
- AI-powered personalization for tailored treatment